Details of the Drug Excipient

General Information of Drug Inactive Ingredient (DIG) (ID: E00687)

• DIG Name: Ammonium hydroxide
• DIG Function: Alkalizing agent

Full List of Drug(s) Co-administrated with This DIG

4 Approved Drug(s) Co-administrated with This DIG

Drug Name	Drug ID	Indication	Formulation Name	Formulation ID
Cabozantinib	DMIYDT4	Thyroid cancer [2D10]	Cabozantinib S-Malate eq 80mg base capsule	F23394
Cysteamine	DMSYFM8	Nephropathic cystinosis [5C60]	Cysteamine Bitartrate eq 50mg base capsule	F23414
Raltegravir	DMYURI6	Human immunodeficiency virus infection [1C62]	Raltegravir Potassium eq 100mg base/packet powder	F23528
Talazoparib	DM1KS78	Breast cancer [2C60-2C65]	Talazoparib 0.25 mg capsule	F24298

1 Clinical Trial Drug(s) Co-administrated with This DIG

Drug Name	Drug ID	Indication	Formulation Name	Formulation ID
Selumetinib	DMC7W6R	Melanoma [2C30]	Selumetinib 10 mg capsule	F23891